We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00408889
First Posted: December 7, 2006
Last Update Posted: April 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Heidelberg University
  Purpose
Early organ failure occurs frequently and is difficult to predict. The study aims to define a predictive score for early transplant failure.

Condition
Liver Transplantation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation

Resource links provided by NLM:


Further study details as provided by Heidelberg University:

Estimated Enrollment: 150
Study Start Date: December 2006
Detailed Description:
Patients will be monitored 7 days following liver transplantation, including clinical scores, clinical chemistry, ultrasound findings and indocyaninegreen-clearance.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing liver transplantation
Criteria

Inclusion Criteria:

  • orthotopic liver transplantation
  • age > 18 years

Exclusion Criteria:

  • allergy to indocyangreen
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00408889


Locations
Germany
University Hospital of Heidelberg
Heidelberg, Germany, 69120
Sponsors and Collaborators
Heidelberg University
Investigators
Principal Investigator: Christoph Eisenbach, Dr. Heidelberg University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00408889     History of Changes
Other Study ID Numbers: post OLT
First Submitted: December 6, 2006
First Posted: December 7, 2006
Last Update Posted: April 9, 2010
Last Verified: December 2008

Keywords provided by Heidelberg University:
liver transplantation
organ failure
outcome